EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Drug‐coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug‐eluting stent: One‐year outcomes and optical coherence tomography assessment

Kentaro Mitsui iD, Tetsumin Lee iD, Ryoichi Miyazaki iD, Nobuhiro Hara iD, Sho Nagamine iD, Tomofumi Nakamura, Mao Terui, Shinichiro Okata, Masashi Nagase, Giichi Nitta, Keita Watanabe, Masakazu Kaneko and 3 more

Catheterization and Cardiovascular Interventions · 2023-07 · 102 (1) · 11-17

DOI: 10.1002/ccd.30689 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, published online on 2023-05-20. Written by Kentaro Mitsui and 14 co-authors. Institution: Department of Cardiology, Japanese Red Cross Musashino Hospital, Musashino City, Tokyo, Japan. Major MEDLINE topics: Percutaneous Coronary Intervention, Drug-Eluting Stents, Coronary Artery Disease, Atherectomy, Coronary. Cited 21 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Percutaneous coronary intervention (PCI) for calcified coronary artery remains challenging in the drug‐eluting stent (DES) era. While recent studies reported the efficacy of orbital atherectomy (OA) combined with DES for calcified lesion, the effectiveness of drug‐coated balloon (DCB) following OA has not been fully elucidated.

Methods

Between June 2018 and June 2021, 135 patients who received PCI for calcified de novo coronary lesions with OA were enrolled and divided into two groups; OA followed by DCB ( n = 43) if the target lesion achieved acceptable preparation, or second‐ or third‐generation DESs ( n = 92) if the target lesion showed suboptimal preparation between June 2018 and June 2021. All patients underwent PCI with optical coherence tomography (OCT) imaging. The primary endpoint was 1‐year major adverse cardiac event (MACE), that was a composite of cardiac death, nonfatal myocardial infarction, or target lesion revascularization.

Results

Mean age was 73 years and 82% was male. In OCT analysis, maximum calcium plaque was thicker (median: 1050 µm [interquartile range (IQR): 945–1175 µm] vs. 960 µm [808–1100 µm], p = 0.017), calcification arc tended to larger (median: 265° [IQR: 209–360°] vs. 222° [162–305°], p = 0.058) in patients with DCB than in DES, and the postprocedure minimum lumen area was smaller in DCB compared with minimum stent area in DES (median: 3.83 mm 2 [IQR: 3.30–4.52 mm 2 ] vs. 4.86 mm 2 [4.05–5.82 mm 2 ], p < 0.001). However, 1 year MACE free rate was not significantly different between 2 groups (90.3% in DCB vs. 96.6% in DES, log‐rank p = 0.136). In the subgroup analysis of 14 patients who underwent follow‐up OCT imaging, late lumen area loss was lower in patients with DCB than DES, despite lower lesion expansion rate in DCB than DES.

Conclusions

In calcified coronary artery disease, DCB alone strategy (if acceptable lesion preparation was performed with OA) was feasible compared with DES following OA with respect to 1‐year clinical outcomes. Our finding indicated using DCB with OA might be reduce late lumen area loss for severe calcified lesion.

Subjects

MeSH terms (MEDLINE)

Percutaneous Coronary InterventionDrug-Eluting StentsCoronary Artery DiseaseAtherectomy, CoronaryHumansMaleAgedTomography, Optical CoherenceCoronary VesselsTreatment OutcomeAtherectomy

Author keywords

ATHY-atherectomyBALD-balloonCAD-coronary artery diseaseDES-stentOCT-optical coherence tomographydirectional/rotationaldrug coated/elutingdrug eluting

Authors and institutions

  • Department of Cardiology, Japanese Red Cross Musashino Hospital, Musashino City, Tokyo, Japan.

ORCID profiles: Kentaro Mitsui, Tetsumin Lee, Ryoichi Miyazaki, Nobuhiro Hara, Sho Nagamine

Cite

APA

Mitsui, K., Lee, T., Miyazaki, R., Hara, N., Nagamine, S., Nakamura, T., Terui, M., Okata, S., Nagase, M., Nitta, G., Watanabe, K., Kaneko, M., Nagata, Y., Nozato, T., & Ashikaga, T. (2023). Drug‐coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug‐eluting stent: One‐year outcomes and optical coherence tomography assessment. Catheterization and Cardiovascular Interventions, 102(1), 11-17. https://doi.org/10.1002/ccd.30689

Vancouver

Mitsui K, Lee T, Miyazaki R, Hara N, Nagamine S, Nakamura T, et al. Drug‐coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug‐eluting stent: One‐year outcomes and optical coherence tomography assessment. Catheterization and Cardiovascular Interventions. 2023;102(1):11-17. doi:10.1002/ccd.30689

BibTeX
@article{Mitsui2023,
  author = {Mitsui, Kentaro and Lee, Tetsumin and Miyazaki, Ryoichi and Hara, Nobuhiro and Nagamine, Sho and Nakamura, Tomofumi and Terui, Mao and Okata, Shinichiro and Nagase, Masashi and Nitta, Giichi and Watanabe, Keita and Kaneko, Masakazu and Nagata, Yasutoshi and Nozato, Toshihiro and Ashikaga, Takashi},
  title = {Drug‐coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug‐eluting stent: One‐year outcomes and optical coherence tomography assessment},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  volume = {102},
  number = {1},
  pages = {11--17},
  doi = {10.1002/ccd.30689}
}
Start for free →